Third, butyrate slows the progression of atherosclerosis, which is linked to the reduction in CD36 levels in macrophages and endothelial cells, decline in pro-inflammatory cytokine levels, and lower nuclear factor-κB activation level [41]. The gene discussed is CD36; the disease is atherosclerosis.